1. On the Cusp: New Approaches for Multiple Myeloma

2. Program Goals

3. MM Novel Therapies

4. ELOQUENT-2 Phase 3 Trial Design

5. ELOQUENT-2 Efficacy and Safety Data

6. Elotuzumab +/- Vd Phase 2 Trial Design

7. Elotuzumab +/- Vd Phase 2 Trial Efficacy and Safety Data

8. MMY2002 SIRIUS Daratumumab Phase 2 Trial

9. ENDEAVOR Phase 3 Trial Design

10. ENDEAVOR Efficacy and Safety Data

11. CHAMPION-1 Once-Weekly Carfilzomib Phase 1/2 Trial

12. PANORAMA 1 Design, Efficacy, and Safety Data

13. PANORAMA 1 Subgroup Analysis

14. Panobinostat Other Combinations in RRMM

15. New Approaches for MM Summary

16. Abbreviations

17. Abbreviations (cont)

18. References

19. References (cont)

20. References (cont)

21. References (cont)